Return to Search
EN
Thrombocytosis is a condition characterized by a platelet (PLT) count exceeding 450,000 per microliter of blood. This condition can lead to an increased risk of blood clots or stroke. Common symptoms may include headache, chest pain, fainting spells, temporary vision disturbances, numbness or tingling in the extremities (hands and feet), and dizziness.
A high platelet count generally indicates excessive platelet production in the bone marrow, and comprehensive tests are essential to determine the underlying cause. Observed more frequently in older age, a bone marrow-derived high platelet count is defined as "essential thrombocytosis" and requires effective treatment.
Treatment approaches are determined based on the evaluation of the patient's risk profile. Low-risk individuals, typically those under 60 years of age with no prior history of thrombosis, are usually advised to take low-dose blood thinners such as acetylsalicylic acid. For patients with significantly high platelet counts or those in the high-risk group, anticoagulant (blood thinner) therapy is administered alongside medications designed to reduce the platelet count.
What is High Platelet Count (Thrombocytosis)?
A high platelet count generally indicates excessive platelet production in the bone marrow, and comprehensive tests are essential to determine the underlying cause. Observed more frequently in older age, a bone marrow-derived high platelet count is defined as "essential thrombocytosis" and requires effective treatment.
Treatment approaches are determined based on the evaluation of the patient's risk profile. Low-risk individuals, typically those under 60 years of age with no prior history of thrombosis, are usually advised to take low-dose blood thinners such as acetylsalicylic acid. For patients with significantly high platelet counts or those in the high-risk group, anticoagulant (blood thinner) therapy is administered alongside medications designed to reduce the platelet count.